Stocks · Technology · Services-Prepackaged Software

BiomX Inc.

PHGE Clue Score33
United States Fiscal year ends December CIK 0001739174 Results filed 12 Nov 2025

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Reuven Yeganeh
17 Mar 2026
Director
Sold after exercise indirect
530,000
$5.00
$2.65M
Reuven Yeganeh
16 Mar 2026
Director
Sold after exercise indirect
450,000
$5.00
$2.25M
Reuven Yeganeh
13 Mar 2026
Director
Sold after exercise indirect
370,000
$5.00
$1.85M
Reuven Yeganeh
12 Mar 2026
Director
Sold after exercise indirect
300,000
$5.00
$1.50M
OrbiMed Israel BioFund GP Limited Partnership
15 May 2024
10% owner
Sold after exercise indirect
24,344
$0.38
$9.28K

What was left out

Form 4 filings counted 121
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 65
Transactions with no price 3
Shares from compensation/vesting 42,932,639
Sales filed before the plan box existed 62
History held since 19 Dec 2018